Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Treasury Shares (2021 - 2025)

Historic Treasury Shares for PROCEPT BioRobotics (PRCT) over the last 5 years, with Q3 2025 value amounting to $2.2 million.

  • PROCEPT BioRobotics' Treasury Shares rose 1299.17% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 1299.17%. This contributed to the annual value of $1.9 million for FY2024, which is 2102.24% up from last year.
  • PROCEPT BioRobotics' Treasury Shares amounted to $2.2 million in Q3 2025, which was up 1299.17% from $2.1 million recorded in Q2 2025.
  • PROCEPT BioRobotics' Treasury Shares' 5-year high stood at $2.2 million during Q3 2025, with a 5-year trough of $35000.0 in Q4 2021.
  • For the 5-year period, PROCEPT BioRobotics' Treasury Shares averaged around $1.4 million, with its median value being $1.5 million (2023).
  • Its Treasury Shares has fluctuated over the past 5 years, first soared by 202000.0% in 2022, then soared by 279.72% in 2025.
  • Over the past 5 years, PROCEPT BioRobotics' Treasury Shares (Quarter) stood at $35000.0 in 2021, then soared by 2020.0% to $742000.0 in 2022, then surged by 110.92% to $1.6 million in 2023, then increased by 21.02% to $1.9 million in 2024, then rose by 15.26% to $2.2 million in 2025.
  • Its last three reported values are $2.2 million in Q3 2025, $2.1 million for Q2 2025, and $2.1 million during Q1 2025.